Inaktiver Wert

Andere Sprachen Precision Therapeutics Inc Nasdaq

Aktien

US74033P1003

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024	10.05.
Predictive Oncology : Material Agreement - Form 8-K	06.05.
Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts	01.05.
Investors Await Fed Rate Decision as US Futures Trend Lower in Wednesday's Premarket	01.05.
Top Premarket Gainers	01.05.
Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine	30.04.
Predictive Oncology Inc. Announces Significant Progress with FluGen in Development of Intranasal Flu Vaccine	30.04.
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting	25.04.
FUJIFILM Wako Chemicals U.S.A. Corporation and Predictive Oncology Announce Collaboration to Reduce Protein Interference in Bacterial Endotoxin Detection Testing of Biopharmaceuticals	25.04.
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24.04.
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update	28.03.
Predictive Oncology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Predictive Oncology to Participate in Upcoming Investor Conferences	21.02.
Predictive Oncology Inc. Announces Resignation of Pamela Bush, as Chief Business Officer, Effective from February 15, 2024	08.02.
Predictive Oncology to Participate in Upcoming San Francisco Conferences	02.01.
Earnings Flash (POAI) PREDICTIVE ONCOLOGY Posts Q3 Revenue $715,056	14.11.
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update	14.11.
Predictive Oncology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13.11.
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital	09.11.
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital	08.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Precision Therapeutics Inc Nasdaq

Aktien

US74033P1003

Andere Sprachen

Filter